| Literature DB >> 30397634 |
Anne Carolus1, Roland Schroers2, Iris Tischoff3, Kirsten Schmieder1, Christopher Brenke1.
Abstract
A 51 year old man presented with progressive swelling in the upper arm. MRI revealed a solitary mass extending from the median nerve. Intraoperative finding was a tumour extending within the nerve in its proximal fibres. The histological result showed a Castleman disease.Entities:
Keywords: Peripheral nerve tumour; infiltrative growing tumour; surgery; unicentric Castleman disease
Year: 2018 PMID: 30397634 PMCID: PMC6211252 DOI: 10.1080/23320885.2018.1525301
Source DB: PubMed Journal: Case Reports Plast Surg Hand Surg ISSN: 2332-0885
Tumours of the peripheral nerve system.
| MPNST | BPNST | MPNNST | BPNNST |
|---|---|---|---|
| MPNST | –schwannomas (= neurilemmomas/neuinomas) –neurofibromas | –metastasis (lung, breast, melanoma) –sarcomas –lymphomas | –ganglioncysts –hypertrophic neuropathy –lipomas –venous angiomas –hemangiopericytomas –hemangioblastomas –myositis ossificans –ostochondromas –ganglioneuromas –meningeomas –cystic hygromas –myoblastomas –granular cell tumors –epidermoid cysts –desmoids |
MPNST: Malignant peripheral nerve sheath tumour; BPNST: Benign peripheral nerve sheath tumour; MPNNST: Malignant peripheral non neural sheath tumour; BPNNST: Benign peripheral non neural sheath tumour.
Figure 1.MRI of the upper arm showing a spindle shaped contrast enhancing mass in the median nerve course. (a) coronar view (b) axial view.
Figure 2.Intraoperative views of tumour dissection and removal. (a) Opening the capsule of the tumour and electric stimulation of fascicle-like structures. (b) Exposed tumour with a smooth surface in its middle part. (c) Exposed tumour, infiltrative growing in its proximal ending (arrow). (d) Tumorbed after removal of the median part, rest tumour embedding a nerve branch (arrow).
Figure 3.Histological stain sections. (a) Immunhistochemical staining for T-cells within the interfollicular zone. (b) In 10× HE stain section areas with high endothelial venules are demonstrated. (c) Immunhistochemical expression of CD20 demonstrating regressed germinal centers. (d) Immunhistochemical expression of CD23 shows extended network of follicular dendritic cells.